HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heather J Ribaudo Selected Research

Art Therapy

11/2023Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
4/2023Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.
1/2023Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
10/2022Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
12/2020Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.
1/2020Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
1/2016Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
8/2015Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
1/2015Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.
3/2013Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heather J Ribaudo Research Topics

Disease

31Acquired Immunodeficiency Syndrome (AIDS)
10/2023 - 08/2004
17Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 05/2011
11Infections
04/2023 - 04/2004
8HIV Infections (HIV Infection)
05/2024 - 12/2010
8Inflammation (Inflammations)
01/2024 - 07/2013
5Atherosclerosis
03/2024 - 01/2017
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2023 - 03/2013
3Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 01/2023
3Hyperbilirubinemia
09/2015 - 02/2013
2Insulin Resistance
05/2011 - 04/2007
1Non-alcoholic Fatty Liver Disease
11/2023
1Neoplasms (Cancer)
10/2023
1Diabetes Mellitus
08/2023
1COVID-19
04/2023
1Weight Gain
01/2023
1Obesity
12/2021
1Hypertension (High Blood Pressure)
12/2021
1Jaundice (Icterus)
09/2015
1Tuberculosis (Tuberculoses)
04/2014
1Hepatitis C
12/2013
1Pregnancy Complications
12/2012
1Disease Progression
05/2011
1Myocardial Infarction
04/2011
1Virus Diseases (Viral Diseases)
12/2010

Drug/Important Bio-Agent (IBA)

15efavirenz (Sustiva)FDA Link
02/2015 - 04/2004
7Ritonavir (Norvir)FDA Link
02/2019 - 02/2013
7abacavir (Ziagen)FDA Link
02/2015 - 04/2004
6Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2015
6Atazanavir Sulfate (Reyataz)FDA Link
02/2019 - 01/2013
5pitavastatin (itavastatin)FDA Link
05/2024 - 08/2023
5RNA (Ribonucleic Acid)IBA
11/2023 - 08/2006
5Darunavir (Prezista)FDA Link
02/2019 - 01/2013
5NucleosidesIBA
04/2007 - 04/2004
4LDL CholesterolIBA
03/2024 - 04/2007
4LipidsIBA
03/2024 - 04/2007
4Zidovudine (Retrovir)FDA LinkGeneric
08/2013 - 04/2004
4Lamivudine (Epivir)FDA Link
08/2013 - 04/2004
4Reverse Transcriptase InhibitorsIBA
03/2010 - 04/2004
3CalciumIBA
12/2023 - 11/2017
3C-Reactive ProteinIBA
11/2023 - 05/2011
3Proteins (Proteins, Gene)FDA Link
10/2023 - 12/2010
3Raltegravir PotassiumFDA Link
02/2019 - 10/2014
3Emtricitabine (Emtriva)FDA Link
02/2019 - 08/2013
3Protease Inhibitors (Protease Inhibitor)IBA
08/2015 - 04/2004
3LopinavirFDA Link
05/2015 - 11/2011
2Immunoglobulin G (IgG)IBA
01/2024 - 01/2023
2HDL CholesterolIBA
11/2023 - 04/2007
2Integrase InhibitorsIBA
12/2021 - 08/2015
2Glucose (Dextrose)FDA LinkGeneric
12/2021 - 04/2007
2Methotrexate (Mexate)FDA LinkGeneric
12/2020 - 01/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 01/2020
2Tenofovir (Viread)FDA Link
02/2019 - 08/2013
2oxidized low density lipoproteinIBA
01/2019 - 04/2007
2BilirubinIBA
09/2015 - 09/2015
2Interleukin-6 (Interleukin 6)IBA
08/2015 - 03/2013
2Nevirapine (Viramune)FDA Link
08/2013 - 03/2010
2Cytochrome P-450 CYP2B6 (CYP2B6)IBA
12/2012 - 09/2010
1Blood Proteins (Serum Proteins)IBA
04/2023
1Granzymes (Granzyme)IBA
04/2023
1CI 22IBA
01/2023
1IntegrasesIBA
01/2023
1Illicit Drugs (Recreational Drugs)IBA
02/2019
1omega-Chloroacetophenone (Mace)IBA
01/2019
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2019
1Sitagliptin Phosphate (Januvia)FDA Link
01/2019
1ChemokinesIBA
01/2019
1Lipoproteins (Lipoprotein)IBA
01/2017
1HDL LipoproteinsIBA
01/2017
1fibrin fragment D (D-dimer)IBA
08/2015
1Lipopolysaccharide ReceptorsIBA
08/2015
1Antiviral Agents (Antivirals)IBA
08/2015
1Peptides (Polypeptides)IBA
12/2010
1Amino AcidsFDA Link
12/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2010
1Cytochrome P-450 CYP3AIBA
09/2010
1Triglycerides (Triacylglycerol)IBA
04/2007
1CholesterolIBA
04/2007
1Indinavir (Crixivan)FDA Link
08/2004
1Nelfinavir (Viracept)FDA Link
08/2004
1Stavudine (Zerit)FDA LinkGeneric
08/2004

Therapy/Procedure

13Therapeutics
03/2024 - 08/2004
10Art Therapy
11/2023 - 03/2013
2Highly Active Antiretroviral Therapy (HAART)
01/2022 - 12/2012
1Treatment Delay
04/2014
1Aftercare (After-Treatment)
02/2006